Role of class I and class II histone deacetylases in carcinoma cells using siRNA.

[1]  K. Glaser,et al.  Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. , 2003, Molecular cancer therapeutics.

[2]  Chun Li Zhang,et al.  Class II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophy , 2002, Cell.

[3]  K. Glaser,et al.  Transforming growth factor beta mimetics: discovery of 7-[4-(4-cyanophenyl)phenoxy]-heptanohydroxamic acid, a biaryl hydroxamate inhibitor of histone deacetylase. , 2002, Molecular cancer therapeutics.

[4]  Fred Asselbergs,et al.  Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family* , 2002, The Journal of Biological Chemistry.

[5]  Ricky W. Johnstone,et al.  Histone-deacetylase inhibitors: novel drugs for the treatment of cancer , 2002, Nature Reviews Drug Discovery.

[6]  R. Evans,et al.  Isolation and Characterization of Mammalian HDAC10, a Novel Histone Deacetylase* , 2002, The Journal of Biological Chemistry.

[7]  N. Rosen,et al.  The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells. , 2001, Cancer research.

[8]  P. Pandolfi,et al.  Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia. , 2001, The Journal of clinical investigation.

[9]  Richard A. Rifkind,et al.  Cloning and characterization of a histone deacetylase, HDAC9 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Guenther,et al.  The SMRT and N-CoR Corepressors Are Activating Cofactors for Histone Deacetylase 3 , 2001, Molecular and Cellular Biology.

[11]  A. Wolffe,et al.  Chromatin remodeling: why it is important in cancer , 2001, Oncogene.

[12]  S. Kern,et al.  High-Throughput Drug Screening of the DPC4 Tumor-Suppressor Pathway in Human Pancreatic Cancer Cells , 2001, Annals of surgery.

[13]  K. Shin‐ya,et al.  Spiruchostatins A and B, novel gene expression-enhancing substances produced by Pseudomonas sp. , 2001 .

[14]  R. Weinberg,et al.  Ski/Sno and TGF-β signaling , 2001 .

[15]  T. Ekström,et al.  The human histone deacetylase family. , 2001, Experimental cell research.

[16]  M. Yoshida,et al.  Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Schreiber,et al.  Genomewide studies of histone deacetylase function in yeast. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R A Rifkind,et al.  Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. , 2000, Cancer research.

[19]  P. Marks,et al.  Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  K. Shin‐ya,et al.  Diheteropeptin, a new substance with TGF-beta-like activity, produced by a fungus, Diheterospora chlamydosporia. I. Production, isolation and biological activities. , 2000, The Journal of antibiotics.

[21]  J. Qin,et al.  Both corepressor proteins SMRT and N‐CoR exist in large protein complexes containing HDAC3 , 2000, The EMBO journal.

[22]  P. Marks,et al.  Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. , 2000, Journal of the National Cancer Institute.

[23]  S. Kern,et al.  A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library. , 2000, Cancer research.

[24]  T. Nakayama,et al.  N-terminal Region, C-terminal Region, Nuclear Export Signal, and Deacetylation Activity of Histone Deacetylase-3 Are Essential for the Viability of the DT40 Chicken B Cell Line* , 2000, The Journal of Biological Chemistry.

[25]  A. Bird,et al.  Histone deacetylases: silencers for hire. , 2000, Trends in biochemical sciences.

[26]  R. Evans,et al.  Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. , 2000, Genes & development.

[27]  K. Miyazono,et al.  c-Ski Acts as a Transcriptional Co-repressor in Transforming Growth Factor-β Signaling through Interaction with Smads* , 1999, The Journal of Biological Chemistry.

[28]  P. Marks,et al.  Chemoprevention of carcinogen-induced mammary tumorigenesis by the hybrid polar cytodifferentiation agent, suberanilohydroxamic acid (SAHA). , 1999, Anticancer research.

[29]  T. Tsuruo,et al.  A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  P. Marks,et al.  Hybrid polar inducers of transformed cell differentiation/apoptosis. From the cell to the clinic. , 1999, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[31]  P. Marks,et al.  A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  K. Shin‐ya,et al.  A novel substance with TGF-beta like activity, diheteropeptin, produced by a fungus, Diheterospora sp. , 1997, Journal of antibiotics (Tokyo. 1968).

[33]  R. Lotan,et al.  Modulation of growth and differentiation of human colon carcinoma cells by histone deacetylase inhibitory trichostatins. , 1996, International journal of oncology.

[34]  H. Kwon,et al.  Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines. , 1994, Experimental cell research.

[35]  N. Nomura,et al.  Isolation of human cDNA clones of ski and the ski-related gene, sno. , 1989, Nucleic acids research.

[36]  F. Dequiedt,et al.  Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. , 2002, Molecular cell.

[37]  J. Davie,et al.  Signal transduction pathways and the modification of chromatin structure. , 2001, Progress in nucleic acid research and molecular biology.

[38]  P. Marks,et al.  Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers. , 2001, Blood cells, molecules & diseases.

[39]  Sarantseva Sv,et al.  [Molecular-genetic analysis of radiation-induced mutation of the white gene, inserted in the 45D region of the second Drosophila melanogaster chromosome]. , 1992 .